Clinical Study of Brain Natriuretic Peptide of Coronary Heart Disease with Heart Failure and Effect of Tongguan Capsule 振源胶囊治疗冠心病心绞痛临床观察冠心病心力衰竭患者BNP水平及通冠胶囊的影响
Outcome of Percutaneous Coronary Intervention in Coronary Artery Disease with Severe Left Ventricular Dysfunction; Effect of percutaneous coronary interventions on heart function in patients with coronary heart disease and heart failure disease 冠心病左心功能不全患者经皮冠状动脉介入治疗疗效研究经皮冠状动脉介入治疗对冠心病合并心力衰竭患者疗效评价
Correlation between level of serum uric acid and heart failure in Uygur nationality male coronary heart disease patients with heart failure 维吾尔族男性冠心病心力衰竭与血清尿酸的相关性高同型半胱氨酸血症与冠心病心力衰竭的相关性
The clinical observation for the coronary heart disease complicated with heart failure by Trimetazidine treatment 曲美他嗪治疗冠心病心力衰竭效果的临床研究
Retrospective Analysis on Elder Inpatients with Coronary Chronic Heart Failure 老年冠心病慢性心力衰竭住院患者回顾性分析
The reports about coronary heart disease, heart failure and arrhythmia during the74th AHA academic annual meeting are reviewed. 综述了第74届AHA学术年会会议期间有关冠心病、心衰和心律失常方面的报告。
Studies have shown that patients with coronary heart disease or heart failure may suffer from decreased amounts and impaired function of peripheral circulating EPC. 大量试验证实冠心病和心力衰竭患者内皮祖细胞数量减低,外周循环内皮祖细胞功能受损,许多因素可影响内皮祖细胞的数量及功能。
Objective To explore the clinical effect of metoprolol combined with trimetazidine used for coronary disease combined with cardiac failure. 目的探讨美托洛尔联合曲美他嗪治疗冠心病心力衰竭患者临床疗效。
Curative effect of levosimendan on patients with coronary artery disease complicated acute heart failure 左西孟坦治疗冠心病伴急性心力衰竭的疗效
Effect of atorvastatin on improvement of cardiac function in patients with coronary heart disease and heart failure 阿托伐他汀改善冠心病心力衰竭患者心功能的作用
The Clinical Significance of Detecting Plasma BNP in Coronary Disease Patinets without Heart Failure 冠心病无心衰患者血浆脑钠素水平检测的临床意义
Discussion of Relationship Between Heart Structure and Arrhythmia in Coronary Heart Disease Patients with Heart Failure 冠心病心力衰竭患者心脏结构与心律失常关系的探讨
Research of Coronary Heart Disease Risk Factors in Heart Failure of Uighur Male Patients with Coronary Heart Disease 冠心病危险因子在维吾尔族冠心病心力衰竭中的研究
Results clinically, it was difficult to differentiate hypertension with chest pain and coronary heart failure, but dynamic EDG and typical angina pectoris suggested the possibility of coronary heart disease. 结果两者之间临床上较难鉴别,但动态心电图与典型心绞痛可高度提示冠心病的可能。
Effect of percutaneous coronary intervention on refractory heart failure secondary to ischemia in patients with chronic total occlusion and collateral circulation PCI治疗慢性闭塞病变伴侧支循环的缺血性顽固性心力衰竭
Clinical significance of left atrium enlargement in coronary heart disease patients with diastolic heart failure 左房扩大在冠心病舒张性心力衰竭中的临床意义
Echocardiographic Study on Left Ventricular Function in Patients with Coronary Artery Disease Complicated with Heart Failure 冠心病并发心力衰竭患者左窒功能的超声心动图研究
Objective: Angiotensin-converting enzyme inhibitor ( ACEI) have been widely managing cardiovascular disease and cerebrovascular disease, example for hypertension, coronary arterial disease, congestive heart failure and cerebral apoplexy. 背景:目前血管紧张素转换酶抑制剂(angiotensin-convertingenzymeinhibitorACEI)类药物广泛应用治疗心脑血管疾病,如高血压、冠心病、心力衰竭、脑卒中等。
Conclusions Based on the medication of oral digitalis, diuretics and angiotension-converting enzyme inhibitors, carvedilol therapy can improve left ventricular performance, reverse LV remodeling in patients of coronary heart disease with heart failure and also improve the biological properties of the chronically failing heart. 结论在强心、利尿、血管紧张素转化酶抑制剂治疗的基础上,应用卡维地洛能显著改善缺血性心脏病心力衰竭患者的心功能,改善心室重塑。
Nursing care of coronary heart disease patients complicated with pump failure treated with intra-aortic balloon counterpulsation 主动脉内球囊反搏治疗冠心病合并泵衰竭病人的护理
Objective To study the changes of the content of antiarrhythmic peptide ( AAP) in chronic heart diseases ( such as atrial fibrillation of rheumatic valvular heart disease, frequent ventricular extrasystoles of coronary heart disease, and chronic heart failure). 目的探讨慢性心律失常发生的常见疾病,如风湿性心脏病心房颤动、冠心病频发室性期前收缩及慢性心力衰竭患者血清中抗心律失常肽(AAP)含量的变化。
The change of the plasma thyroid hormone in patients with coronary heart disease and heart failure 冠心病心力衰竭患者血甲状腺激素的变化
The postoperative complications incidence of the patients included was 14.28%. These complications were hematoma, hypotension, coronary artery spasm, acute heart failure, hematuria. 结果全部患者并发症发生率为14.28%,分别为局部出血及血肿、低血压、冠状动脉痉挛、急性左心衰竭、血尿。
However, the precise mechanism is not clear. At present, it is considered that a chronic inflammatory state and neurohumoral activation contribute to adverse clinical outcomes in patients with coronary artery disease and those with heart failure. 但是相关的机制尚不明确,目前认为慢性炎症反应和神经元的激活对于患有心力衰竭和冠心病的患者都是预后不良的因素。